Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.

King LDW. et al, (2024), Cell reports. Medicine, 5

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial

Silk SE. et al, (2024), The Lancet Infectious Diseases

Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies

Alanine DGW. et al, (2019), Cell, 178, 216 - 228.e21

Structural Basis for the Acceleration of Procollagen Processing by Procollagen C-Proteinase Enhancer-1

Pulido D. et al, (2018), Structure, 26, 1384 - 1392.e3

Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides

Pulido D. et al, (2018), European Journal of Medicinal Chemistry, 152, 590 - 599

Host Antimicrobial Peptides: The Promise of New Treatment Strategies against Tuberculosis

Arranz-Trullén J. et al, (2017), Frontiers in Immunology, 8

Structural similarities in the CPC clip motif explain peptide-binding promiscuity between glycosaminoglycans and lipopolysaccharides

Pulido D. et al, (2017), Journal of The Royal Society Interface, 14, 20170423 - 20170423

Crystal Structure of the Heterotrimeric Integrin-Binding Region of Laminin-111

Pulido D. et al, (2017), Structure, 25, 530 - 535

Crystallographic analysis of the laminin β2 short arm reveals how the LF domain is inserted into a regular array of LE domains

Pulido D. et al, (2017), Matrix Biology, 57-58, 204 - 212

Structural basis for endotoxin neutralization by the eosinophil cationic protein

Pulido D. et al, (2016), The FEBS Journal, 283, 4176 - 4191

A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities

Pulido D. et al, (2016), Antimicrobial Agents and Chemotherapy, 60, 6313 - 6325

The first crystal structure of human RNase 6 reveals a novel substrate-binding and cleavage site arrangement

Prats-Ejarque G. et al, (2016), Biochemical Journal, 473, 1523 - 1536

Insights into the Antimicrobial Mechanism of Action of Human RNase6: Structural Determinants for Bacterial Cell Agglutination and Membrane Permeation

Pulido D. et al, (2016), International Journal of Molecular Sciences, 17, 552 - 552

Protein post‐translational modification in host defense: the antimicrobial mechanism of action of human eosinophil cationic protein native forms

Salazar VA. et al, (2014), The FEBS Journal, 281, 5432 - 5446

Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus

Torrent M. et al, (2013), Biochemical Journal, 456, 99 - 108

Towards the rational design of antimicrobial proteins

Pulido D. et al, (2013), The FEBS Journal, 280, 5841 - 5852

Two Human Host Defense Ribonucleases against Mycobacteria, the Eosinophil Cationic Protein (RNase 3) and RNase 7

Pulido D. et al, (2013), Antimicrobial Agents and Chemotherapy, 57, 3797 - 3805

Exploring New Biological Functions of Amyloids: Bacteria Cell Agglutination Mediated by Host Protein Aggregation

Torrent M. et al, (2012), PLoS Pathogens, 8, e1003005 - e1003005

Structural determinants of the eosinophil cationic protein antimicrobial activity

Boix E. et al, (2012), bchm, 393, 801 - 815

Antimicrobial Peptide Action on Parasites

Torrent M. et al, (2012), Current Drug Targets, 13, 1138 - 1147

Load More

Include forthcoming?